The Balanced Adherence Metric (BAM): a new spin on current methods for calculating adherence with pharmacy claims data. Bill Simpson, B.Sc, Ph.D (1,2) and Amos Adler, M.Sc. (2) McMaster University, Hamilton, Ontario, Canada MEMOTEXT Corporation, Toronto, Ontario, Canada Purpose/Objective: While Proportion of Days Covered (PDC) quantifies adherence (from claims data) in patients […]
Although I don’t know him personally, Joseph Kvedar is someone who I look up to. He’s been at the forefront of digital health for many years and a leader in the identification, validation and application of digital health. In this paper, Joseph Kvedar, Alexander Fogel, Eric Elenko & Daphne Zohar describe key advances, the marketplace […]
Digital health is turning into one of those catch-all terms that people use to describe everything from electronic medical records to smartphone apps to wearable devices. While I’m happy that the world is starting to pay attention, I’ve noticed a worrying trend. We have a multitude of devices creating tremendous amounts of patient data, but […]
Posted on March 15, 2016 by Mary Camp Another HIMSS conference makes it three in a row for me. I feel like a veteran and enjoyed sharing my inside tips for rookies: arrive early for your sessions to get a seat, choose comfort over style in footwear, pack snacks and water, be prepared to choose sessions based […]
Posted on February 12, 2015
On February 11, 2014, MEMOTEXT was one of the 5 MaRS based mHealth/digital health start-ups, invited to speak at the University of Toronto’s Rotman School of Management’s IT in Healthcare Speaker Series: Start-Ups. MEMOTEXT Founder and President Amos Adler spoke about how MEMOTEXT’s mhealth/digital health communication platform cuts costs for all stakeholders in the healthcare system and delivers clinically proven increases to adherence.
Posted on February 14, 2016 by Amos Adler Being a digital health entrepreneur is an educational experience to say the least. Most lessons are about pain, endurance and learning how to persevere. But I’ve also learned volumes about patients…whom I will call ‘people’ while working to improve medication adherence. While these ramblings could fill a novel, I’ll […]
TORONTO, Feb. 4, 2016 /CNW/ – A 2014 pilot program for patients with chronic diseases by Green Shield Canada (GSC) and MEMOTEXT Corp. has revealed some new facts about non-adherence to medication. Compiled into “The Importance of Sticking to it” whitepaper, data from the Stick2It program shows that a personalized digital health intervention can […]
Posted on January 24, 2016 by Noah Nemoy Advancing the way people interact with their health technology is a pillar of MEMOTEXT’s mission. The greatest part about working on so many different programs for different stakeholders, is that we get to learn how people interact or refrain from engaging with their health. Learning from programs that allowed us to […]
Posted on January 24, 2016 by Noah Nemoy As a valued MEMOTEXT client we’d like to give you a sneak peek at our latest technological advancement: SAM! SAM is the MEMOTEXT ChatBot for your health. It’s mission is to remind and support patients in adherence to their medication regimen. SAM is MEMOTEXT’s mobile automated chatbot/smart adherence bot that […]
Looking back on MEMOTEXT’s accomplishments this fall
Posted on December 2, 2015 by Noah Nemoy
This autumn has been an exciting time for MEMOTEXT. In September our Founder and President Amos Adler had the opportunity to be a main stage speaker at Stanford Medicine X 2015. Presenting the abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” Amos rocked the crowd explaining the MEMOTEXT methodology. He had a fantastic time at the event and the “Cat pics + health data = behavior change” line got a substantial amount of press coverage.